Business Description
Albireo Pharma Inc
NAICS : 325412
SIC : 2834
ISIN : US01345P1066
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.31 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.31 | |||||
Beneish M-Score | 1.57 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.7 | |||||
3-Year EBITDA Growth Rate | 33.6 | |||||
3-Year EPS without NRI Growth Rate | 23.4 | |||||
3-Year FCF Growth Rate | -34.8 | |||||
3-Year Book Growth Rate | -4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | 136.52 | |||||
12-1 Month Momentum % | 69.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.32 | |||||
Quick Ratio | 6.23 | |||||
Cash Ratio | 5.88 | |||||
Days Inventory | 213.7 | |||||
Days Sales Outstanding | 12.38 | |||||
Days Payable | 930.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.4 | |||||
Shareholder Yield % | -0.07 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 95.56 | |||||
Operating Margin % | -214.17 | |||||
Net Margin % | -228.51 | |||||
FCF Margin % | -208.25 | |||||
ROE % | -91.17 | |||||
ROA % | -46.51 | |||||
ROIC % | -257.7 | |||||
ROC (Joel Greenblatt) % | -12424.56 | |||||
ROCE % | -50.68 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 14.93 | |||||
PB Ratio | 9.13 | |||||
Price-to-Tangible-Book | 11.04 | |||||
EV-to-EBIT | -6.03 | |||||
EV-to-EBITDA | -6.05 | |||||
EV-to-Revenue | 12.98 | |||||
EV-to-Forward-Revenue | 12.61 | |||||
EV-to-FCF | -6.41 | |||||
Price-to-Net-Current-Asset-Value | 51.76 | |||||
Price-to-Net-Cash | 690.17 | |||||
Earnings Yield (Greenblatt) % | -16.58 | |||||
FCF Yield % | -13.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Albireo Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 52.678 | ||
EPS (TTM) (€) | -6.362 | ||
Beta | 0 | ||
Volatility % | 118.89 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0.496429 | ||
20-Day SMA (€) | 0 | ||
12-1 Month Momentum % | 69.74 | ||
52-Week Range (€) | 16.11 - 42.05 | ||
Shares Outstanding (Mil) | 20.74 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Albireo Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Albireo Pharma Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Albireo Pharma Inc Frequently Asked Questions
What is Albireo Pharma Inc(FRA:BDQM)'s stock price today?
When is next earnings date of Albireo Pharma Inc(FRA:BDQM)?
Does Albireo Pharma Inc(FRA:BDQM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |